Healthcare

Shares of Healius (ASX:HLS) surged 11.8% on March 27, reaching A$1.465. This rise was driven by positive financial updates, including a 6.2% year-to-date revenue increase and a 4% jump in volumes for the company’s February results. If these gains hold, Healius is set to …

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE), a biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, has announced the completion of clinical evaluations for the last patient in its ATH434-202 Phase 2 trial. This open-label study is designed to assess the safety, efficacy, …

Telix Pharmaceuticals Ltd (ASX:TLX) continues its upward trajectory, with shares climbing 1.5% in Friday morning trade to AU$28.22. This marks an impressive 112.6% gain over the past year, significantly boosting investor returns.